Wyeth sees new competition for Effexor anti-depressant drug
Categories: Celebs & Entertainment
Effexor, the best-selling anti-depression drug in the world (sales) may now have a new competitor. In what could happen more and more, an Indian pharmaceutical company has applied to the FDA to sell a drug in pill form instead of capsule.
The dinger: the new drug, which will be sold as a generic, will have the same active ingridient at Wyeth's $3.7 billion-a-year Effexor drug. Think that's a threat? Sure -- big-time.
The difference here that makes this potential new anti-depressant such a big deal is because it comes in an extended-release tablet as opposed to a capsule (which is under Wyeth patent protection until 2010). Nothing like finding a loophole for new drug sales, huh?
The dinger: the new drug, which will be sold as a generic, will have the same active ingridient at Wyeth's $3.7 billion-a-year Effexor drug. Think that's a threat? Sure -- big-time.
The difference here that makes this potential new anti-depressant such a big deal is because it comes in an extended-release tablet as opposed to a capsule (which is under Wyeth patent protection until 2010). Nothing like finding a loophole for new drug sales, huh?
Recent Posts
- Jon Gosselin Hits the Yoga Mat (11/06/2009)
- World Run Day 2009 is This Sunday! (11/06/2009)
- Mariah Carey Flaunts A Fuller Figure (11/06/2009)
- Dry on the Fly: Tips and Tricks to Dry Your Hair Fast (11/06/2009)
- Competitive Eater Crazy Legs Conti's Diet and Fitness Routine (11/06/2009)
